Spirulina Supplements: Evidence, B12 and Product Safety

The food ingredient commonly called spirulina is biomass from cyanobacteria such as Arthrospira. A whole-biomass powder, tablet and isolated blue pigment preparation should not be assumed to contain the same constituents or share the same evidence.^{See reference 1}

The artwork shows green powder and tablets alongside a conceptual coiled-filament inset. The inset represents the organism’s form; it is not a measured micrograph. It does not show a tested contaminant level or certify a commercial batch.

The 2023 lipid review combined twenty randomized studies with 1,076 participants and reported improvements in LDL cholesterol, total cholesterol and triglycerides, with an increase in HDL. Populations and protocols varied. The result should be described as a pooled change in measured lipids.^{See reference 3}

That review does not show that the tested products prevented heart attacks or strokes. A favourable laboratory change can be worth further research without becoming a medicine-replacement claim. It also cannot prove that any powder sold under the same ingredient name has the same composition.^{See reference 3}

The 2025 broader synthesis included thirty-five trials and assessed multiple cardiometabolic outcomes. Its certainty ratings differed: several lipid or glucose outcomes were supported by low-quality evidence, while some other outcomes received stronger ratings. One positive endpoint does not upgrade all the others.^{See reference 4}

The studies varied in participants, amounts and duration. A claim about cardiovascular prevention needs clinical event evidence beyond these biomarker results. Avoid using the largest number of pooled trials as a substitute for the quality and relevance of the specific finding.^{See reference 4}

ANSES explains that much of the B12-like material in spirulina is an inactive analogue. This makes it an unreliable way to meet vitamin B12 needs, particularly when a diet otherwise lacks a dependable source. A B12-looking analytical number does not settle biological activity.^{See reference 2}

Do not use a spirulina label to discontinue a reliable B12 source or to interpret a low laboratory result. This page does not choose a deficiency-treatment plan. Its related B12 guide explains that separate nutrient question.

ANSES highlights contamination by cyanotoxins, bacteria and trace metals as relevant safety concerns. These are possible product-quality problems, not proof that every spirulina product is contaminated. The agency also identifies particular caution for people with phenylketonuria or an allergic predisposition.^{See reference 1}

Ask whether quality documentation identifies the product and lot, reports the relevant tests and comes from an appropriate laboratory. A certificate for a different lot, or a front-of-pack purity slogan, leaves an unanswered question. This checklist does not certify that an unexamined product is safe.

The 2011 U.S. Pharmacopeia review assigned a Class A safety rating to the evaluated spirulina ingredients, allowing quality monographs. It reviewed clinical, animal, regulatory and adverse-event information and noted that the classification could be revisited as new information emerged.^{See reference 5}

This supports a standards discussion, not a guarantee of efficacy or of every commercial batch. Keep identity standards, batch contamination checks and benefit studies as separate pieces of evidence. A population-specific medicine or pregnancy question still requires a qualified professional.^{See reference 5}